Trial Profile
Clinical study for apatinib combined with tegafur in the treatment of advanced colorectal cancer and analysis of related prognostic factors
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Oct 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Tegafur (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 16 Oct 2018 New trial record